Journal article
Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
Abstract
BACKGROUND AND AIMS: Achieving sustained virological response (SVR; cure) in hepatitis C patients using a simple regimen is key to making elimination by 2030 possible. In the largest real-world analysis to date, the effectiveness of pangenotypic, panfibrotic, single-tablet, sofosbuvir/velpatasvir (SOF/VEL) once-daily for 12 weeks was assessed in 12 clinical real-world cohorts from various geographical areas, settings and treatment practices. …
Authors
Mangia A; Milligan S; Khalili M; Fagiuoli S; Shafran SD; Carrat F; Ouzan D; Papatheodoridis G; Ramji A; Borgia SM
Journal
Liver International, Vol. 40, No. 8, pp. 1841–1852
Publisher
Wiley
Publication Date
8 2020
DOI
10.1111/liv.14537
ISSN
0106-9543